Masanobu Yamazaki

No ORCID on file · 1 paper in corpus

observational 2026

Fewer Injections and Lower Drug Costs With Long-Acting GnRH Depot Formulations: A Nationwide Analysis of 2.3 Million Patient-Years in Japan

Cancer reports (Hoboken, N.J.) ·doi:10.1002/cnr2.70688

BACKGROUND: Androgen deprivation therapy (ADT) is the base of treatment for prostate cancer, and gonadotropin-releasing hormone (GnRH) drugs are given as depot injections. Long-acting formulations may reduce the number of injections and the…